Clinical Trials
8 trialsNCT02274662 2025-01-16
Expanded Access Protocol Thymus Transplantation
Sumitomo Pharma Switzerland GmbH
Phase 4 Completed
NCT02231879 2023-04-07
Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
National Institutes of Health Clinical Center (CC)
Phase 2/3 Completed
NCT00553098 2020-02-17
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT01049854 2018-08-21
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
New York Medical College
Phase 2 Completed
NCT00517803 2017-08-28
Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT00179790 2017-03-06
Reduced Intensity Transplant Using Extracorporeal Photopheresis
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1/2 Completed
NCT00024934 2016-09-22
B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00015665 2008-03-04
Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections
National Institutes of Health Clinical Center (CC)
Phase 3 Completed